Answers are grounded in this paper and cite their sources.
Preclinical study demonstrates reliable liver tumor induction and catheterization in Oncopigs, highlighting a viable large-animal model for transarterial therapies.
following exposure to Cre recombinase. This pictorial essay illustrates the technical methodology for liver tumor induction in Oncopigs and demonstrates the angiographic use of tumor-bearing animals for evaluation of transarterial therapies. Liver tumors were induced using an ex vivo transgene activation approach in which liver biopsy specimens were incubated with an adenoviral vector expressing Cre recombinase and injected percutaneously into the liver under ultrasound guidance. Tumor development occurred in 34/37 (92%) induction sites across 17 Oncopigs and was confirmed by contrast-enhanced computed tomography. Hepatic arteriography using standard clinical devices enabled selective catheterization of tumor-feeding arteries. This pictorial essay provides a technical guide for investigators studying liver-directed therapies in a translational large-animal model.
No takes yet. Share an insight, caveat, or question.
Elkhadragy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: